Literature DB >> 19966218

Characterization and temporal development of cores in a mouse model of malignant hyperthermia.

Simona Boncompagni1, Ann E Rossi, Massimo Micaroni, Susan L Hamilton, Robert T Dirksen, Clara Franzini-Armstrong, Feliciano Protasi.   

Abstract

Malignant hyperthermia (MH) and central core disease are related skeletal muscle diseases often linked to mutations in the type 1 ryanodine receptor (RYR1) gene, encoding for the Ca(2+) release channel of the sarcoplasmic reticulum (SR). In humans, the Y522S RYR1 mutation is associated with malignant hyperthermia susceptibility (MHS) and the presence in skeletal muscle fibers of core regions that lack mitochondria. In heterozygous Y522S knock-in mice (RYR1(Y522S/WT)), the mutation causes SR Ca(2+) leak and MHS. Here, we identified mitochondrial-deficient core regions in skeletal muscle fibers from RYR1(Y522S/WT) knock-in mice and characterized the structural and temporal aspects involved in their formation. Mitochondrial swelling/disruption, the initial detectable structural change observed in young-adult RYR1(Y522S/WT) mice (2 months), does not occur randomly but rather is confined to discrete areas termed presumptive cores. This localized mitochondrial damage is followed by local disruption/loss of nearby SR and transverse tubules, resulting in early cores (2-4 months) and small contracture cores characterized by extreme sarcomere shortening and lack of mitochondria. At later stages (1 year), contracture cores are extended, frequent, and accompanied by areas in which contractile elements are also severely compromised (unstructured cores). Based on these observations, we propose a possible series of events leading to core formation in skeletal muscle fibers of RYR1(Y522S/WT) mice: Initial mitochondrial/SR disruption in confined areas causes significant loss of local Ca(2+) sequestration that eventually results in the formation of contractures and progressive degradation of the contractile elements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966218      PMCID: PMC2799858          DOI: 10.1073/pnas.0911496106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The spectrum of pathology in central core disease.

Authors:  C A Sewry; C Müller; M Davis; J S M Dwyer; J Dove; G Evans; R Schröder; D Fürst; T Helliwell; N Laing; R C M Quinlivan
Journal:  Neuromuscul Disord       Date:  2002-12       Impact factor: 4.296

2.  REGULATION BY CALCIUM OF THE CONTRACTION AND RELAXATION OF MUSCLE FIBERS.

Authors:  R J PODOLSKY; L L COSTANTIN
Journal:  Fed Proc       Date:  1964 Sep-Oct

3.  CENTRAL "CORE" DISEASE OF SKELETAL MUSCLE. ULTRASTRUCTURAL AND CYTOCHEMICAL OBSERVATIONS IN TWO CASES.

Authors:  N K GONATAS; M C PEREZ; G M SHY; I EVANGELISTA
Journal:  Am J Pathol       Date:  1965-09       Impact factor: 4.307

4.  Central core disease-an investigation of a rare muscle cell abnormality.

Authors:  W K ENGEL; J B FOSTER; B P HUGHES; H E HUXLEY; R MAHLER
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

5.  Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility.

Authors:  Nicole Monnier; Renée Krivosic-Horber; Jean-François Payen; Geneviève Kozak-Ribbens; Yves Nivoche; Pascal Adnet; Hugo Reyford; Joël Lunardi
Journal:  Anesthesiology       Date:  2002-11       Impact factor: 7.892

6.  Central core disease of muscle: clinical, histochemical and electron microscopic studies of an affected mother and child.

Authors:  V Dubowitz; S Roy
Journal:  Brain       Date:  1970       Impact factor: 13.501

7.  Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2001-09       Impact factor: 4.086

Review 8.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle.

Authors:  Paul S Brookes; Yisang Yoon; James L Robotham; M W Anders; Shey-Shing Sheu
Journal:  Am J Physiol Cell Physiol       Date:  2004-10       Impact factor: 4.249

9.  Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

10.  Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region.

Authors:  L Galli; A Orrico; S Cozzolino; V Pietrini; V Tegazzin; V Sorrentino
Journal:  Cell Calcium       Date:  2002-09       Impact factor: 6.817

View more
  57 in total

1.  CIR-Myo News: Proceedings of the 2014 Spring Padua Muscle Days: Terme Euganee and Padova (Italy), April 3-5, 2014.

Authors: 
Journal:  Eur J Transl Myol       Date:  2014-03-27

2.  Elongated mitochondrial constrictions and fission in muscle fatigue.

Authors:  Manuela Lavorato; Emanuele Loro; Valentina Debattisti; Tejvir S Khurana; Clara Franzini-Armstrong
Journal:  J Cell Sci       Date:  2018-12-05       Impact factor: 5.285

3.  Increased mitochondrial nanotunneling activity, induced by calcium imbalance, affects intermitochondrial matrix exchanges.

Authors:  Manuela Lavorato; V Ramesh Iyer; Williams Dewight; Ryan R Cupo; Valentina Debattisti; Ludovic Gomez; Sergio De la Fuente; Yan-Ting Zhao; Héctor H Valdivia; György Hajnóczky; Clara Franzini-Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 4.  Special article: Future directions in malignant hyperthermia research and patient care.

Authors:  Sharon J Hirshey Dirksen; Marilyn Green Larach; Henry Rosenberg; Barbara W Brandom; Jerome Parness; Robert Scott Lang; Meera Gangadharan; Tyler Pezalski
Journal:  Anesth Analg       Date:  2011-06-27       Impact factor: 5.108

5.  Mouse model of severe recessive RYR1-related myopathy.

Authors:  Stephanie Brennan; Maricela Garcia-Castañeda; Antonio Michelucci; Nesrin Sabha; Sundeep Malik; Linda Groom; Lan Wei LaPierre; James J Dowling; Robert T Dirksen
Journal:  Hum Mol Genet       Date:  2019-09-15       Impact factor: 6.150

6.  Oxidative capacity and fatigability in run-trained malignant hyperthermia-susceptible mice.

Authors:  Clement Rouviere; Benjamin T Corona; Christopher P Ingalls
Journal:  Muscle Nerve       Date:  2012-04       Impact factor: 3.217

7.  Bioenergetic defects in muscle fibers of RYR1 mutant knock-in mice associated with malignant hyperthermia.

Authors:  Leon Chang; Xiaochen Liu; Christine P Diggle; John P Boyle; Philip M Hopkins; Marie-Anne Shaw; Paul D Allen
Journal:  J Biol Chem       Date:  2020-08-21       Impact factor: 5.157

Review 8.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

9.  Mitochondrial superoxide flashes: metabolic biomarkers of skeletal muscle activity and disease.

Authors:  Lan Wei; Gheorghe Salahura; Simona Boncompagni; Karl A Kasischke; Feliciano Protasi; Shey-Shing Sheu; Robert T Dirksen
Journal:  FASEB J       Date:  2011-06-06       Impact factor: 5.191

10.  Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.

Authors:  Genaro C Barrientos; Wei Feng; Kim Truong; Klaus I Matthaei; Tianzhong Yang; Paul D Allen; José R Lopez; Isaac N Pessah
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.